Letrozol i fertilitetsbehandling

Translated title of the contribution: Letrozole in fertility treatment

Emilie Steentoft Dahlberg*, Dorte Andersen, Pernilla Skjødt Andersson, Kathrine Birch, Lotte Colmon, Marianne Dreyer Holt, Kasper Ingerslev, Kirstine Kirkegaard, Kristine Løssl, Liv la Cour Poulsen, Marie-Louise Wissing, Mathilde Yde, Nathalie Søderhamn Bülow

*Corresponding author for this work

Abstract

This review describes the current evidence regarding the putative indications of letrozole (LTZ) in fertility treatment. Prior to intrauterine insemination, LTZ is recommended in women with normogonadotrophic oligo-anovulation. In ovulatory women, LTZ is equal to clomiphene and may be used instead of exogenous gonadotrophin. LTZ may be used as co-treatment in poor responders prior to in vitro fertilization/intracytoplasmic sperm injection. In addition, LTZ prior to frozen-thawed embryo transfer is increasingly used in women with normogonadotrophic oligo-anovulation.

Translated title of the contributionLetrozole in fertility treatment
Original languageDanish
Article numberV05230315
JournalUgeskrift for Laeger
Volume185
Issue number41
ISSN0041-5782
Publication statusPublished - 9 Oct 2023

Fingerprint

Dive into the research topics of 'Letrozole in fertility treatment'. Together they form a unique fingerprint.

Cite this